
Kratos is rated a buy, driven by strong Q2 earnings beats and robust forward guidance, despite a recent stock pullback. KTOS's investment thesis centers on resilient near-term revenues, a $2.08B backlog, and expanding production capacity, but hinges on margin improvement. Valuation is stretched—current price implies growth far above guidance; the market is paying for a long-term terminal story, not near-term value.










